SCHEMBL411803

SCHEMBL411803

CCC(C)(C)NC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL156987 0.85 TSHR (0.43) TSHRTDP1
SCHEMBL11461590 0.76 TSHR (0.35) TSHRTDP1
SCHEMBL22007399 0.73 ALDH1A1 (0.39)
SCHEMBL19245901 0.73 TSHR (0.33) TSHRTDP1
SCHEMBL20952956 0.73 TSHR (0.33) TSHRTDP1
SCHEMBL19415093 0.73 TSHR (0.33) TSHRTDP1
SCHEMBL12285415 0.71 TSHR (0.38) TSHRTDP1
SCHEMBL16872763 0.71
SCHEMBL18612961 0.71 TSHR (0.38) TSHRTDP1
SCHEMBL22664282 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4296029-A Process for preparing hexahydroazepine, piperidine and pyrrolidine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1981-10-20 US claimed
EP-3724699-B1 METHOD FOR PRODUCING MPS-COMPATIBLE WATER GRADIENT CONTACT LENSES ALCON INC (CH) 2023-07-26 EP disclosed
US-20230142274-A1 SUBSTITUTED ARYL COMPOUND NANJING ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2023-05-11 US disclosed
CN-108291171-B Synergistic lubricating oil composition containing mixture of olefin copolymer dispersant type viscosity improver and amine compound 雪佛龙奥伦耐有限责任公司 2022-02-01 CN disclosed
US-20210340111-A1 COMPOSITION OF SCALABLE THYROINTEGRIN ANTAGONISTS WITH IMPROVED RETENTION IN TUMORS NANOPHARMACEUTICALS LLC 2021-11-04 US disclosed
US-20210253613-A1 PHOSPHORUS IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF CANWELL BIOTECH LTD (CN) 2021-08-19 US disclosed
EP-2885384-B1 LUBRICANT COMPOSITION COMPRISING ACYCLIC HINDERED AMINES BASF SE (DE) 2021-05-05 EP disclosed
EP-2760958-B1 SYSTEMS, METHODS AND COMPOSITIONS FOR PRODUCTION OF TIE-LAYER ADHESIVES EQUISTAR CHEM LP (US) 2020-08-12 EP disclosed
US-10662391-B2 Lubricating oil compositions containing borated dispersants and amine compounds and methods of making and using same CHEVRON ORONITE COMPANY LLC (US) 2020-05-26 US disclosed
CN-110790725-A Preparation method of lubricating oil additive containing thiadiazole group 太平洋联合(北京)石油化工有限公司 2020-02-14 CN disclosed
EP-0021772-B1 METHOD OF PREPARING 2-OXO- AND 2-UNSUBSTITUTED-HEXAHYDROAZEPINE DERIVATIVES JOHN WYETH & BROTHER LIMITED (GB) 1985-01-02 EP disclosed
EP-0054384-B1 PROCESS FOR PREPARING PYRIDINE DERIVATIVES JOHN WYETH & BROTHER LIMITED (GB) 1984-06-27 EP disclosed
EP-0021552-B1 HEXAHYDROAZEPINE, PIPERIDINE AND PYRROLIDINE DERIVATIVES AND PROCESSES FOR PREPARING THEM JOHN WYETH & BROTHER LIMITED (GB) 1983-01-26 EP disclosed
EP-0054384-A1 Process for preparing pyridine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1982-06-23 EP disclosed
US-4296029-A Process for preparing hexahydroazepine, piperidine and pyrrolidine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1981-10-20 US disclosed
EP-0021772-A1 Method of preparing 2-oxo- and 2-unsubstituted-hexahydroazepine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1981-01-07 EP disclosed
EP-0021552-A1 Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for preparing them JOHN WYETH & BROTHER LIMITED (GB) 1981-01-07 EP disclosed
US-4197241-A Hexahydroazepine, piperidine and pyrrolidine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1980-04-08 US disclosed
EP-0003253-A1 Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for making and using them JOHN WYETH & BROTHER LIMITED (GB) 1979-08-08 EP disclosed
US-4006190-A Production of hydroxyl compounds CELANESE CORPORATION (US) 1977-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253613-A1 PHOSPHORUS IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF TLR8, TLR7, TLR9 TSHR 2135/4885TDP1 976/4885
US-20210340111-A1 COMPOSITION OF SCALABLE THYROINTEGRIN ANTAGONISTS WITH IMPROVED RETENTION IN TUMORS EGFR, TEK, HDGF TSHR 11/4885TDP1 3511/4885
US-20230142274-A1 SUBSTITUTED ARYL COMPOUND RAD51, FANCI, BLM TSHR 3887/4885TDP1 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.